Empa May 20 2025 Special care must be taken with illnesses during pregnancy, as not all drugs are compatible for mother and child. This is why an international research team involving Empa is now developing nanomedicines that will enable safe and effective treatment of inflammatory processes during pregnancy. Pregnancy complications are often caused or accompanied by inflammation, but the treatment options are often not sufficiently effective or are suspected of interfering with the development